26 Multiple Sclerosis Clinical Trials in Atlanta, GA (2026)

Q: How do I join a clinical trial in Atlanta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you.

Recruiting Multiple Sclerosis Studies in Atlanta

NCT01255748Recruiting

Registry Study for Radiation Therapy Outcomes

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy....

Atlanta, GA50,000 participantsProton Collaborative Group

View Study Details

NCT00900198Recruiting

Collection of Tissue Samples for Cancer Research

Background: -Patients who are being evaluated and/or treated at the NIH Clinical Center and adult patients at participating sites will be entered onto this tissue procurement protocol for collection ...

Atlanta, GA5,000 participantsNational Cancer Institute (NCI)

View Study Details

NCT00756665Recruiting

Prostate Active Surveillance Study

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close mo...

Atlanta, GA3,000 participantsUniversity of Washington

View Study Details

NCT07318558Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for OC may start with surgery to remove as much of the cancer as possible. After surgery, people may receive chemot...

Atlanta, GAPHASE3900 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07287098Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

This study will include two groups of patients: Cohort 1 and Cohort 2. Cohort 1: will help researchers learn how a medicine called imlunestrant (LY3484356) affects a specific type of breast cancer. S...

Atlanta, GAPHASE2600 participantsEli Lilly and Company

View Study Details

NCT05614739Recruiting

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-435 by itself or when it is combined with other standard medicines that treat cancer. LOXO-435...

Atlanta, GAPHASE1535 participantsEli Lilly and Company

View Study Details

NCT06628570Recruiting

Screening Strategies Among High-risk Populations for Anal Cancer

The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squamous intraepithelial lesion (aHSIL), a precancerous condition of anal cancer, a...

Atlanta, GANA500 participantsLisa Flowers

View Study Details

NCT07114601Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relevant standard of care (SOC) combination therapy in participants with Gastrin-rele...

Atlanta, GAPHASE1421 participantsEli Lilly and Company

View Study Details

NCT07525843Recruiting

A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

The goal of this pragmatic clinical trial is to learn if the WE BEAT program, a 5-week group-based online wellbeing and skill-building program, can help teens with congenital heart disease (CHD) impro...

Atlanta, GANA390 participantsCarelon Research

View Study Details

NCT06095089Recruiting

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

The purpose of Parts 1, 2A, and 2B of the study is to determine the recommended regimen for Phase 2 (RP2Rs) of combination of JNJ-87189401 with JNJ-78278343 and the purpose of Part 2C of this study is...

Atlanta, GAPHASE1355 participantsJanssen Research & Development, LLC

View Study Details

NCT04429087Recruiting

A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

This study is open to adults with small cell lung cancer and other neuroendocrine cancers that are positive for the tumour marker delta-like 3 (DLL3). The study is in people with advanced cancer for w...

Atlanta, GAPHASE1300 participantsBoehringer Ingelheim

View Study Details

NCT05394428Recruiting

A Multi Center Study of Sexual Toxicities After Radiotherapy

The purpose of this research is to understand how radiotherapy and other cancer treatments impact sexual function in female cancer patients and to try to answer a question about why some patients who ...

Atlanta, GA300 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT04192344Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

This is an open-label phase 1 study to determine the safety and tolebility of oral ABSK021 in patients with advanced solid tumor as well as the Recommended Phase 2 dose (RP2D) of oral ABSK021. Prelimi...

Atlanta, GAPHASE1276 participantsAbbisko Therapeutics Co, Ltd

View Study Details

NCT03391778Recruiting

Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion....

Atlanta, GAPHASE1250 participantsUSWM CT, LLC

View Study Details

NCT06150157Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

The purpose of this study is to characterize safety and to determine the Recommended Phase 2 Dose (RP2D\[s\]) and optimal dosing schedule(s) of JNJ-88549968 in part 1 (Dose Escalation); to characteriz...

Atlanta, GAPHASE1241 participantsJanssen Research & Development, LLC

View Study Details

NCT06919965Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

The main purpose of this study is to compare the disease-free survival (the length of time after randomization that a participant survives without any signs or symptoms of the cancer returning, or pro...

Atlanta, GAPHASE3220 participantsJanssen Research & Development, LLC

View Study Details

NCT07441694Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

This study will be conducted to determine the safety, tolerability, dose-limiting toxicity (DLT)s, and maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE)s of INCA036978 administe...

Atlanta, GAPHASE1218 participantsIncyte Corporation

View Study Details

NCT07129252Recruiting

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

This Phase 1/2, multicenter, open-label, FIH study aims to evaluate the safety, tolerability, PK, and preliminary antitumor activity of CRN09682 in participants with SST2-expressing NENs and other sol...

Atlanta, GAPHASE1150 participantsCrinetics Pharmaceuticals Inc.

View Study Details

NCT06495138Recruiting

Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization tra...

Atlanta, GANA138 participantsEmory University

View Study Details

NCT07042516Recruiting

Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).

This Randomized Clinical Trial entitled Safety and Efficacy of a Peripherally Restricted Selective Kappa Agonist for Moderate to Severe Menopausal Symptoms in Midlife Women is a Phase 2a randomized, d...

Atlanta, GAPHASE2120 participantsTioga Pharmaceuticals

View Study Details

NCT06271252Recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

The is a first clinical study for Oricell Therapeutics Inc. in the United States to evaluate the safety, PK, PD and preliminary efficacy of our anti-GPRC5D cell product (OriCAR-017) in subjects with r...

Atlanta, GAPHASE181 participantsOriCell Therapeutics Co., Ltd.

View Study Details

NCT07667322Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple Sclerosis

The main purpose of this study is to evaluate the safety and tolerability of the ocrelizumab subcutaneous (SC) test formulation in participants with multiple sclerosis (MS). The study consists of two ...

Atlanta, GAPHASE175 participantsHoffmann-La Roche

View Study Details

NCT06919900Recruiting

Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis

The primary purpose of this interventional study is to examine the overall motor learning capacity from exposure to repeated perturbations among ambulatory people with multiple sclerosis (MS). This pr...

Atlanta, GANA64 participantsGeorgia State University

View Study Details

NCT06796504Recruiting

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

The MS pilot study will assess the safety and investigate the remyelinating effects of the SetPoint System (study device) in adult patients with patients diagnosed with relapsing-remitting multiple sc...

Atlanta, GANA60 participantsSetPoint Medical Corporation

View Study Details

NCT05985161Recruiting

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

The purpose of this study is to find out whether selinexor is an effective treatment for people who have a relapsed/refractory Wilms tumor, rhabdoid tumor, MPNST, or another solid tumor that makes a h...

Atlanta, GAPHASE245 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06629428Recruiting

Effects of Ublituximab on Motor Functions in Multiple Sclerosis

The purpose of this study is to test if ublituximab changes walking functions and fall risk in people with relapsing multiple sclerosis (RMS). Twenty-five qualified people with RMS will undergo a 48-w...

Atlanta, GAEARLY_PHASE125 participantsGeorgia State University

View Study Details

About Multiple Sclerosis Clinical Trials in Atlanta

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 26 multiple sclerosis clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 64,264 participants. Research is being sponsored by Proton Collaborative Group, National Cancer Institute (NCI), University of Washington and 18 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Atlanta — FAQ

Are there multiple sclerosis clinical trials in Atlanta?

Yes, there are 26 multiple sclerosis clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 26 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 17, 2026 from ClinicalTrials.gov